What is "inflammation"? Are we ready to move beyond Celsus?

British Journal of Sports Medicine

Volumn 38, Issue 3, 2004, Pages 248-249

  Scott, A ^a   Khan, K M ^a   Cook, J L ^b   Duronio, V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

BLOOD CLOTTING; CELL ACTIVATION; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; CYTOLOGY; EDEMA; HUMAN; HYPOXIA; INFLAMMATION; INFLAMMATORY CELL; NEOVASCULARIZATION (PATHOLOGY); NEUROGENIC INFLAMMATION; PAIN; SHORT SURVEY; SPORTS MEDICINE; THROMBOCYTE ACTIVATION; VIBRATION;

HISTORY, ANCIENT; HUMANS; INFLAMMATION; TERMINOLOGY;

EID: 2942550479     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2003.011221     Document Type: Short Survey

References (13)

1. Rocha e Silva M. A brief survey of the history of inflammation. 1978. Agents Actions 1994;43:86-90.
2. Benaroyo L. [How do we define inflammation?]. Schweiz Rundsch Med Prax 1994;83:1343-7.
3. Gallin JI, Snyderman R. Overview. In: Gallin JI, Snyderman R, eds. Inflammation: basic principles and clinical correlates, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:1-4.
4. MacIntyre DL, Reid WD, McKenzie DC. Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications. Sports Med 1995;20:24-40.
5. Khan KM, Cook JL. Overuse tendon injuries: where does the pain come from? Sports Med Arthrosc Rev 2000;8:17-31.
6. Cotran RS. Inflammation: historical perspectives. In: Gallin JI, Snyderman R, eds. Inflammation: basic principles and clinical correlates, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:5-10.
7. Leadbetter WB. An introduction to sport-induced soft-tissue inflammation. In: Leadbetter WB, Buckwalter JA, Gordon SL, eds. Sports-induced inflammation. Park Ridge, IL: American Academy of Orthopaedic Surgeons, 1989:3-23.
8. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
9. Soter NA, Wasserman SI. Physical urticaria/angioedema: an experimental model of mast cell activation in humans. J Allergy Clin Immunol 1980;66:358-65.
10. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000;52:237-68.
11. Wang JH. IOC Workshop on Tendinopathies, Athens, Greece, 2003.
12. Almekinders LC, Banes AJ, Ballenger CA. Effects of repetitive motion on human fibroblasts. Med Sci Sports Exerc 1993;25:603-7.
13. Stovitz S, Johnson R. NSAIDs and musculoskeletal treatment: what is the clinical evidence? Phys Sportsmed 2003;31:21-7.